MPS  Vol.2 No.4 , October 2012
A Case of CD34-Negative Superficial Acral Fibromyxoma
ABSTRACT
Superficial acral fibromyxoma (SAF) is a tumor that occurs on the distal phalanges of the digits. As it does not spontaneously regress and is often associated with pain, the primary treatment is surgical resection. It is often associated with the nail component of the affected digit, and thus cosmesis is an important goal of the operation. We herein describe a case of SAF on the distal phalanges of the fifth digit of the foot beneath the nail, which was successfully resected with the nail component kept intact. Moreover, although SAF is most commonly CD34-positive, the present case was CD34-negative except for endothelial cells within the tumor. While CD34-negative SAF has been previously reported, the current case further indicates that CD34-positivity is not essential for the diagnosis of SAF.

Cite this paper
M. Furuichi, K. Okabe and K. Kishi, "A Case of CD34-Negative Superficial Acral Fibromyxoma," Modern Plastic Surgery, Vol. 2 No. 4, 2012, pp. 77-79. doi: 10.4236/mps.2012.24018.
References
[1]   J. F. Fetsch, W. B. Laskin and M. Miettinen, “Superficial Acral Fibromyxoma: A Clinicopathologic and Immunohistochemical Analysis of 37 Cases of a Distinctive Soft Tissue Tumor with a Predilection for the Fingers and Toes,” Human Pathology, Vol. 32, No. 7, 2001, pp. 704-714. doi:10.1053/hupa.2001.25903

[2]   R. J. Prescott, E. A. Husain, A. Abdellaoui, R. M. Al-Mahmoud, M. Khan and W. D. Salman, “Superficial Acral Fibromyxoma: A Clinicopathological Study of New 41 Cases from the UK: Should Myxoma (NOS) and Fibroma (NOS) Continue as Part of 21st-Century Reporting?” British Journal of Dermatology, Vol. 159, No. 6, 2008, pp. 1315-1321. doi:10.1111/j.1365-2133.2008.08798.x

[3]   O. Quaba, A. Evans, A. A. Al-Nafussi and A. Nassan, “Superficial Acral Fibromyxoma,” British Journal of Plastic Surgery, Vol. 58, No. 4, 2005, pp. 561-564. doi:10.1016/j.bjps.2004.03.006

[4]   G. Pasquinelli, L. Foroni, F. Papadopoulos, L. Dicandia and M. Bisceglia, “Superficial Acral Fibromyxoma: Immunohistochemical and Ultrastructural Analysis of a Case, with Leterature Review,” Ultrastructural Pathology, Vol. 33, No. 6, 2009, pp. 293-301. doi:10.3109/01913120903359768

[5]   J. C. Tardío, M. Butrón, L. M. Martín-Fragueiro, “Superficial Acral Fibromyxoma: Report of 4 Cases With CD10 Expression and Lipomatous Component, Two Previously Underrecognized Features,” The American Journal of Dermatopathology, Vol. 30, No. 5, 2008, pp. 431-435. doi:10.1097/DAD.0b013e31817eec0f

[6]   H. Ashby-Richardson, G. S. Rogers and M. J. Stadecker, “Superficial Acral Fibromyxoma: An Overview,” Archives of Pathology & Laboratory Medicine, Vol. 135, No. 8, 2011, pp. 1064-1066. doi:10.5858/2009-0684-RSR1

[7]   M. Chattopadhyay, P. Farrant, E. Higgins, R. Hay and E. Calonje, “A Nodular Lesion of the Toe. Superficial Acral Fibromyxoma (SAF),” Clinical and Experimental Dermatology, Vol. 35, No. 7, 2010, pp. 807-809. doi:10.1111/j.1365-2230.2010.03789.x

[8]   N. Misago, T. Ohkawa, T. Yanai and Y. Narisawa, “Superficial Acral Fibromyxoma on the Tip of the Big Toe: Expression of CD10 and Nestin,” Journal of the European Academy of Dermatology and Venereology, Vol. 22, No. 2, 2008, pp. 255-257.

 
 
Top